CompletedNCT03274440
Cannabis or Placebo and Obsessive-Compulsive Symptoms
About this title
Read the official source — NCT03274440Researchers compared Cannabis and placebo to find out how the approaches affected obsessive thoughts and compulsive behaviours in people with OCD.
Medication studyAges 21–55United States
Understand this study
What did researchers investigate?
Researchers compared Cannabis and placebo to find out how the approaches affected obsessive thoughts and compulsive behaviours in people with OCD.
Who was this study for?
Listed age limits: 21 years to 55 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateStarted: October 1, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 14
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 21 Years to 55 Years
- Official registry ID
- NCT03274440
- Official title
Show the full official title
Effects of Marijuana on Symptoms of Obsessive-Compulsive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared Cannabis and placebo to find out how the approaches affected obsessive thoughts and compulsive behaviours in people with OCD.
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Cannabis.
Who was this study for?
Listed age limits: 21 years to 55 years.
